Structural analysis and Caco-2 cell permeability of the celiac-toxic A-gliadin peptide 31-55

Journal of Agricultural and Food Chemistry

Volumn 61, Issue 5, 2013, Pages 1088-1096

  Iacomino, Giuseppe ^a   Fierro, Olga ^a   D'Auria, Sabato ^b   Picariello, Gianluca ^a   Ferranti, Pasquale ^a,c   Liguori, Claudia ^b   Addeo, Francesco ^a,c   Mamone, Gianfranco ^a  

^a CNR   (Italy)

^b INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

brush border membrane enzymes; Caco 2 cell; celiac disease; gastropancreatic digestion; gliadin; innate immunity

Indexed keywords

BRUSH BORDER MEMBRANES; CACO-2 CELLS; CELIAC DISEASE; GLIADIN; INNATE IMMUNITY;

AMIDES; AMINO ACIDS; CELL MEMBRANES; COLUMN CHROMATOGRAPHY; ENZYMES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; MASS SPECTROMETRY; MONOLAYERS; POSITIVE IONS;

PEPTIDES;

GLIADIN; PEPTIDE FRAGMENT;

ARTICLE; CELIAC DISEASE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CHEMISTRY; CIRCULAR DICHROISM; EPITHELIUM CELL; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PATHOPHYSIOLOGY; PROTEIN TRANSPORT; TANDEM MASS SPECTROMETRY; WHEAT;

CACO-2 CELLS; CELIAC DISEASE; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; EPITHELIAL CELLS; FLOW CYTOMETRY; GLIADIN; HUMANS; IMMUNITY, INNATE; PEPTIDE FRAGMENTS; PROTEIN TRANSPORT; TANDEM MASS SPECTROMETRY; TRITICUM;

TRITICUM AESTIVUM;

EID: 84873390041     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf3045523     Document Type: Article

References (47)

1. Gianfrani, C.; Auricchio, S.; Troncone, R. Adaptive and innate immune responses in celiac disease Immunol. Lett. 2005, 99, 141-145
2. Wieser, H. Chemistry of gluten proteins Food Microbiol. 2007, 24, 115-119
3. Wieser, H. Prolamins in cereals. In Changing Features of Coeliac Disease; Lohiniemi, S.; Collin, P.; Maki, M., Eds.; The Finnish Coeliac Society: Tampere, Finland, 1998; pp 25-30.
4. Hausch, F.; Shan, L.; Santiago, N. A.; Gray, G. M.; Khosla, C. Intestinal digestive resistance of immunodominant gliadin peptides Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283, G996-1003
5. Sturgess, R. P.; Ellis, H. J.; Ciclitira, P. J. Cereal chemistry, molecular biology, and toxicity in coeliac disease Gut 1991, 32, 1055-60
6. Ciccocioppo, R.; Di Sabatino, A.; Corazza, G. R. The immune recognition of gluten in coeliacdisease Clin. Exp. Immunol. 2005, 140, 408-416
7. Molberg, O.; Mcadam, S. N.; Körner, R.; Quarsten, H.; Kristiansen, C.; Madsen, L.; Fugger, L.; Scott, H.; Norén, O.; Roepstorff, P.; Lundin, K. E.; Sjöström, H.; Sollid, L. M. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease Nat. Med. 1998, 4, 713-717
8. Arentz-Hansen, H.; Korner, R.; Mölberg, Ø.; Quarsten, H.; Vader, W.; Kooy, Y. M. C.; Lundin, K. E. A.; Koning, F.; Roepstorf, P.; Sollid, L. M.; McAdam, S. N. The intestinal T-cell response to a a -gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase J. Exp. Med. 2000, 191, 603-612
9. Shan, L.; Molberg, O.; Parrot, I.; Hausch, F.; Filiz, F.; Gray, G. M.; Sollid, L. M.; Khosla, C. Structural basis for gluten intolerance in celiac sprue Science 2002, 297, 2275-2279
10. Bethune, M. T.; Siegel, M.; Howles-Banerji, S.; Khosla, C. Interferon-γ released by gluten-stimulated celiac disease-specific intestinal T Cells enhances the transepithelial flux of gluten peptides J. Pharmacol. Exp. Ther. 2009, 329, 657-66
11. Barone, M. V.; Gimigliano, A.; Castoria, G.; Paolella, G.; Maurano, F.; Paparo, F.; Maglio, M.; Mineo, A.; Miele, E.; Nanayakkara, M.; Troncone, R.; Auricchio, S. Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease Gut 2007, 56, 480-488
12. Barone, M. V.; Nanayakkara, M.; Paolella, G.; Maglio, M.; Vitale, V.; Troiano, R.; Ribecco, M. T.; Lania, G.; Zanzi, D.; Santagata, S.; Auricchio, R.; Troncone, R.; Auricchio, S. Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation PLoS One 2010, 5, e12246
13. Barone, M. V.; Zanzi, D.; Maglio, M.; Nanayakkara, M.; Santagata, S.; Lania, G.; Miele, E.; Ribecco, M. T.; Maurano, F.; Auricchio, R.; Gianfrani, C.; Ferrini, S.; Troncone, R.; Auricchio, S. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking PLoS One 2011, 6, e17039
14. Comino, I.; Real, A.; Vivas, S.; Síglez, M.á.; Caminero, A.; Nistal, E.; Casqueiro, J.; Rodríguez-Herrera, A.; Cebolla, A.; Sousa, C. Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces Am. J. Clin. Nutr. 2012, 95, 670-677
15. Maiuri, L.; Troncone, R.; Mayer, M.; Coletta, S.; Picarelli, A.; De Vincenzi, M.; Pavone, V.; Auricchio, S.. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa Scand. J. Gastroenterol. 1996, 31, 247-253
16. De Ritis, G.; Auricchio, S.; Jones, H. W.; Lew, E.; Bernardin, J. E.; Kasarda, D. D. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in coeliac disease Gastroenterology 1988, 94, 41-49
17. Maiuri, L.; Ciacci, C.; Ricciardelli, I.; Vacca, L.; Raia, V.; Auricchio, S.; Picard, J.; Osman, M.; Quaratino, S.; Londei, M. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease Lancet 2003, 362, 30-37
18. Mamone, G.; Ferranti, P.; Rossi, M.; Roepstorff, P.; Fierro, O.; Malorni, A.; Addeo, F. Identification of a peptide from alpha-gliadin resistant to digestive enzymes: implications for celiac disease J. Chromatogr., B 2007, 855, 236-241
19. Mineo, H.; Hara, H.; Shigematsu, N.; Okuhara, Y.; Tomita, F. Melibiose, difructose anhydride III and difructose anhydride IV enhance net calcium absorption in rat small and large intestinal epithelium by increasing the passage of tight junctions in vitro J. Nutr. 2002, 132, 3394-3399
20. Garen, A.; Levinthal, C. A fine-structure genetic and chemical study of the enzyme alkaline phosphatase of E. coli. I. Purification and characterization of alkaline phosphatase Biochim. Biophys. Acta 1960, 38, 470-483
21. Delie, F.; Rubas, W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model Crit. Rev. Ther. Drug Carrier Syst. 1997, 14, 221-286
22. Sambruy, Y.; Ferruzza, S.; Ranaldi, G.; De Angelis, I. Intestinal cell culture models: Applications in toxicology and pharmacology Cell Biol. Toxicol. 2001, 17, 301-317
23. Schumann, M.; Richter, J. F.; Wedell, I.; Moos, V.; Zimmermann-Kordmann, M. Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue Gut 2008, 57, 747-754
24. Elli, L.; Dolfini, E.; Bardella, M. T. Gliadin cytotoxicity and in vitro cell cultures Toxicol. Lett. 2003, 146, 1-8
25. Giovannini, C.; Matarrese, P.; Scazzocchio, B.; Varí, R.; D'Archivio, M.; Straface, E.; Masella, R.; Malorni, W.; De Vincenzi, M. Wheat gliadin induces apoptosis of intestinal cells via an autocrine mechanism involving Fas-Fas ligand pathway FEBS Lett. 2003, 540, 117-124
26. Sander, G. R.; Cummins, A. G.; Henshall, T.; Powell, B. C. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins FEBS Lett. 2005, 579, 4851-4855
27. Gesquiere, J. C.; Diesis, E.; Cung, M. T.; Tartar, A. Slow isomerization of some proline-containing peptides inducing peak splitting during reversed-phase high-performance liquid chromatography J. Chromatogr., A 1989, 478, 121-129
28. O'Neal, K. D.; Chari, M. V.; Mcdonald, C. H.; Cook, R. G.; Yu-Lee, L. Y.; Morrisett, J. D.; Shearer, W. T. Multiple cis-trans conformers of the prolactin receptor proline-rich motif (PRM) peptide detected by reverse-phase HPLC, CD and NMR spectroscopy Biochem. J. 1996, 315, 833-844
29. Kálmán, A.; Thunecke, F.; Schmidt, R.; Schiller, P. W.; Horváth, C. Isolation and identification of peptide conformers by reversed-phase high-performance liquid chromatography and NMR at low temperature J Chromatogr., A 1996, 729, 155-171
30. Henderson, D. E.; Mello, J. A. Physicochemical studies of biologically activepeptides by low-temperature reversed-phase high-performance liquid chromatography J. Chromatogr. 1990, 499, 79-88
31. Yang, J. T.; Wu, C. S. C.; Martinez, H. M. Calculation of protein conformation from circular dichroism Methods Enzymol. 1986, 130, 208-269
32. Artursson, P.; Palm, K.; Luthman, K. Caco-2 monolayers in experimental and theoretical predictions of drug transport Adv. Drug Delivery Rev. 2001, 46, 27-43
33. Rauhavirta, T.; Qiao, S. W.; Jiang, Z.; Myrsky, E.; Loponen, J.; Korponay-Szabó, I. R.; Salovaara, H.; Garcia-Horsman, J. A.; Venäläinen, J.; Männistö, P. T.; Collighan, R.; Mongeot, A.; Griffin, M.; Mäki, M.; Kaukinen, K.; Lindfors, K. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A Clin. Exp. Immunol. 2011, 164, 127-136
34. Lebreton, C.; Ménard, S.; Abed, J.; Moura, I. C.; Coppo, R.; Dugave, C.; Monteiro, R. C.; Fricot, A.; Traore, M. G.; Griffin, M.; Cellier, C.; Malamut, G.; Cerf-Bensussan, N.; Heyman, M. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides Gastroenterology 2012, 1043, 698-707
35. Visser, J.; Rozing, J.; Sapone, A.; Lammers, K.; Fasano, A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms Ann. N.Y. Acad. Sci. 2009, 1165, 195-205
36. Lammers, K. M.; Lu, R.; Brownley, J.; Lu, B.; Gerard, C.; Thomas, K.; Rallabhandi, P.; Shea-Donohue, T.; Tamiz, A.; Alkan, S.; Netzel-Arnett, S.; Antalis, T.; Vogel, S. N.; Fasano, A. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3 Gastroenterology 2008, 135, 194-204
37. Föger, F.; Kopf, A.; Loretz, B.; Albrecht, K.; Bernkop- Schnürch, A. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs Amino Acids 2008, 35, 233-241
38. Matysiak-Budnik, T. C.; Candalh, C.; Cellier, C.; Dugave, A.; Namane, T. Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease Gastroenterology 2005, 129, 786-796
39. Matysiak-Budnik, T. C.; Candalh, C.; Dugave, A.; Namane, C.; Cellier, N.; Cerf-Bensussan, N.; Heyman, M. Alterations of the intestinal transport and processing of gliadin peptides in celiac disease Gastroenterology 2003, 125, 696-707
40. Biagi, F.; Ellis, H. J.; Parnell, N. D.; Shidrawi, R. G.; Thomas, P. D. A non-toxic analogue of a coeliac-activating gliadin peptide: A basis for immunomodulation? Aliment. Pharmacol. Ther. 1999, 13, 945-950
41. Andreotti, A. H. Native state proline isomerization: An intrinsic molecular switch Biochemistry 2003, 42, 9515-9524
42. Min, L.; Fulton, D. B.; Andreotti, A. H. A case study of proline isomerization in cell signaling Front. Biosci. 2005, 10, 385-397
43. Göthel, S. F.; Marahiel, M. A. Peptidyl-prolylcis-trans isomerases, a superfamily ofubiquitous folding catalysts Cell. Mol. Life Sci. 1999, 55, 423-436
44. Coste, F.; Kemp, C.; Bobezeau, V.; Hetru, C.; Kellenberger, C.; Imler, J. L.; Roussel, A. Crystal structure of Diedel, a marker of the immune response of Drosophilamelanogaster PLoS One 2012, 7e33416
45. Spadaccini, R.; Temussi, P. A. Natural peptide analgesics: the role of solutionconformation Cell. Mol. Life Sci. 2001, 58, 1572-1582
46. Raiborg, C.; Bache, K. G.; Mehlum, A.; Stang, E.; Stenmark, H. Hrs recruits clathrin to early endosomes EMBO J. 2001, 20, 5008-5021
47. Raiborg, C.; Bache, K. G.; Mehlum, A.; Stenmark, H. Function of Hrs in endocytic trafficking and signalling Biochem. Soc. Trans. 2001, 29, 472-475